A single study showed that the combined RB-negative/p16-positive/cyclin D1-negative tumors in NSCLC might relate to the adverse outcomes, but the independent role of each proteins (p16INK4 and RB1) in the unfavorable prognosis was not confirmed [17]. Here, CDKN2A is linked to non-small cell lung carcinoma.